MDA (3,4-methylenedioxyamphetamine) is typically detectable in urine for 1 to 3 days after use. The exact window depends on the type of test, the dose taken, and individual factors like metabolism and body composition. Here’s what to expect for each testing method.
Detection Times by Test Type
Different drug tests have different look-back windows for MDA:
- Urine: 1 to 3 days after use. This is the most common testing method. Federal screening tests use an initial cutoff of 500 ng/mL, with a confirmatory cutoff of 250 ng/mL.
- Blood: 1 to 2 days (roughly 24 to 48 hours). MDA is absorbed into the bloodstream within a couple of hours after ingestion, but it clears relatively quickly.
- Saliva (oral fluid): 1 to 2 days. Oral fluid tests use a lower cutoff of 50 ng/mL for initial screening and 25 ng/mL for confirmation, making them more sensitive per milliliter than urine tests.
- Hair: Up to 90 days. Hair testing captures a roughly three-month history of repeated drug use. Labs typically test the first 1.5 inches of hair from the root. A single use is less likely to trigger a positive result on a hair test compared to repeated use.
These are approximate ranges. A heavier dose or repeated dosing over a short period can push detection toward the longer end of each window.
How MDA Is Processed in the Body
MDA is closely related to MDMA (ecstasy). In fact, when someone takes MDMA, their body breaks a portion of it down into MDA as a byproduct. This means MDA can show up on a drug test even if the substance originally taken was MDMA, not MDA itself.
MDA’s elimination from the body is somewhat complex. Research on MDMA poisoning cases found that MDA blood levels can remain relatively stable for an extended period, hovering around the same concentration from roughly 6 to 28 hours after ingestion. This plateau happens because MDA is simultaneously being created (as MDMA breaks down) and eliminated. When MDA is taken on its own rather than formed from MDMA, the clearance curve is more straightforward, but the drug still lingers longer than many people expect.
MDMA itself has a plasma half-life of about 5 hours, meaning half the drug is cleared from blood roughly every 5 hours. MDA’s half-life is generally similar or slightly longer, though precise figures vary between individuals. It takes about 5 to 6 half-lives for a substance to drop below detectable levels in blood, which is why the 1 to 2 day blood detection window holds for most people.
Factors That Affect How Long MDA Stays
The ranges above are averages. Several things can shorten or extend your personal detection window.
Body fat plays a role because MDA and its byproducts can accumulate in fatty tissue, releasing slowly over time. People with higher body fat percentages may test positive slightly longer than leaner individuals at the same dose. Metabolism matters too: younger people and those with faster metabolic rates tend to clear the drug more quickly.
Hydration and kidney function influence urine detection times. Well-hydrated individuals produce more dilute urine, which can bring concentrations closer to the cutoff threshold sooner. That said, labs flag samples that appear overly dilute, which can trigger a retest. Liver health is another variable, since the liver is responsible for breaking MDA down into inactive compounds that the kidneys then filter out.
Dose is the most straightforward factor. A larger dose simply means more of the drug needs to be processed, and that takes longer. Redosing (taking a second dose before the first has cleared) compounds this effect and can extend detection times noticeably.
What Drug Tests Actually Look For
Standard drug panels that screen for MDMA also detect MDA. Federal workplace testing guidelines group the two together under a single category. If you test positive on an initial immunoassay screen, the sample goes to a confirmatory test that specifically identifies MDA at a cutoff of 250 ng/mL in urine or 25 ng/mL in oral fluid. This confirmation step rules out false positives from other amphetamine-like compounds.
Not all drug panels include MDMA/MDA. A basic 5-panel test (the kind used for many employment screenings) tests for amphetamines broadly, and MDA may or may not trigger a positive depending on the specific assay. Extended panels, such as 10- or 12-panel tests, are more likely to specifically include MDMA and MDA as separate targets. If you’re unsure what a particular test covers, the testing provider or ordering organization can clarify which substances are included.